Recent Blog Articles
Poison ivy: Scratchin’ like a hound?
Apps to accelerometers: Can technology improve mental health in older adults?
Opioid addiction and overdoses are increasingly harming Black communities
New Harvard tool helps fact-check cancer claims
Hand pain from arthritis? This may help
Polio: What parents need to know now
Ketamine for treatment-resistant depression: When and where is it safe?
Have lupus? What to know about birth control
Screening at home for memory loss: Should you try it?
Travel tummy troubles: Here’s how to prevent or soothe them
Promising results for a targeted drug in advanced prostate cancer
- By Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Diseases
About the Author
Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Diseases
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
thanks from your site and Beneficial Articles.
pls connect me to a letter about cancer treatment with
nano gold particles.
is this testing available now to anyone?
Hi Charles, thanks for getting this blog out. Interesting conclusion of the study.. “Treatment with the PARP inhibitor olaparib in patients whose prostate cancers were no longer responding to standard treatments and who had defects in DNA-repair genes led to a high response rate.” This is a field that we will be paying more attention to later.
Commenting has been closed for this post.
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!